A new Fujirebio Diagnostics blood test identifies beta-amyloid, a brain plaque that is a key marker for Alzheimer’s disease.

Dr. James Galvin, the Director of the University of Miami Miller School of Medicine’s Comprehensive Center for Brain Health, describes how the new center’s goal is to better treat and prevent degenerative brain diseases like Alzheimer’s and Lewy Body Dementia through research studies and seeing patients. Bobbi Rutt is one of those patients.